MolecuLight, the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announced that the company has partnered with Tissue Analytics, a Net Health company that provides software solutions for the wound care industry.
The move will help clinical in decision making and hasten workflows. The purpose of the partnership is to integrate the MolecuLight platform with Net Health’s Tissue Analytics application programming interface (API) program.
Wound care clinicians can now upload standard and fluorescence images captured with the MolecuLight i:X device to the patient’s record in the EHR (electronic health record) platform. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally.
Also Read: New AI Tool to Detect Melanoma
“The MolecuLight i:X is the only point-of-care device enabling clinicians to capture wound images that depict the presence of clinically significant bacteria, and these are extremely helpful in informing clinical decision making to ensure the fastest path to healing,” said Anil Amlani, MolecuLight’s CEO. “The integration with Tissue Analytics via the API program will greatly assist in incorporating this additional information into existing documentation protocols.”
The device provides immediate information on the presence of elevated bacterial burden in wounds, which has dramatically improved our treatment planning and patient care, says medical professional using the product.
“The advances seen in wound care technology over the past five years are remarkable and provide many benefits to patients, payers and the healthcare industry as a whole,” said Josh Pickus, CEO of Net Health.
